Compugen Ltd.

CGEN

Healthcare Biotechnology

Compugen Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $72.8 million, up 161.1% from fiscal 2024.

Revenue
+107.0%
EPS
+12.5%
Free cash flow
−155.4%

Quarter to June 2026, against a year earlier

1.96 0.04 +2.08%
Market cap
$185.7M
P/E
5.2×
Fwd P/E
n/m
Dividend yield
—
F-score
7/9
ROIC
0.00%
Net debt / EBITDA
−4.7×
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Piotroski F-Score
7 5 4 3 — — — — — 2
P/E ratio
4.14 0.00 0.00 0.00 0.00 0.00 — 0.00 — 0.00
P/S ratio
1.96 4.92 11.31 3.96 22.92 48.68 — 6.72 — 364.28
Altman Z-Score
(0.37) (3.87) (2.81) (4.74) 4.19 27.57 — (4.47) — 14.57
P/FCF ratio
1.41 2.16 0.00 0.00 0.00 0.00 — 0.00 — 0.00
Altman Z″-Score (non-manufacturers)
(0.84) (8.87) (7.46) (8.19) (2.53) 1.74 — (16.25) — (1.40)
P/Operating CF
4.52 2.76 (6.84) (2.40) (14.14) (37.64) — (4.68) — (10.13)
Beneish M-Score
(1.59) (5.68) 5.58 (2.68) (1.69) — — — — (5.65)
P/B ratio
1.39 2.49 2.67 0.79 3.39 8.05 — 3.22 — 4.08
EV/Sales
(0.04) 1.21 8.01 (1.44) 15.46 42.39 — 4.16 — 277.86
EV/EBITDA
0.00 0.00 0.00 0.52 0.00 0.00 — 0.00 — 0.00
EV/FCF
(0.03) 0.53 (1.13) 0.24 (3.17) (10.00) — (1.10) — (3.32)
Current Ratio
6.56 5.26 4.36 7.23 7.21 12.27 6.60 4.66 5.03 13.22
Net Debt/EBITDA
(4.65) 6.46 3.99 2.40 3.40 4.04 1.57 2.09 0.85 1.98
Debt/Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
44.84% (23.63%) (26.19%) (36.55%) (30.20%) (37.57%) (72.35%) (67.93%) (79.87%) (41.07%)
ROA
26.03% (12.04%) (17.40%) (29.77%) (25.29%) (30.92%) (51.12%) (49.17%) (67.46%) (36.97%)
ROIC
0.00% 0.00% (55.97%) 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% (1,022.31%)
Return on Tangible Assets
28.02% (16.42%) (20.95%) (44.49%) (31.73%) (24.69%) (67.47%) (56.55%) (125.09%) (49.30%)
Average Days of Receivables
11.95 35.92 693.03 117.63 332.15 850.09 0.00 18.52 0.00 591.07
Earnings Yield
24.18% (10.18%) (11.00%) (56.34%) (9.30%) (3.06%) — (18.34%) — (12.16%)
Free Cash Flow Yield
71.14% 46.22% (62.89%) (150.38%) (21.27%) (8.71%) — (56.50%) — (22.97%)
Free Cash Flow per Share
0.34 0.55 (0.41) (0.40) (0.27) (0.36) (0.43) (0.24) (0.61) (0.44)
Book value per Share
1.10 0.61 0.75 0.90 1.27 1.51 0.60 0.67 0.57 1.25
Free Cash Flow
31.33 49.49 (36.06) (34.59) (23.04) (28.44) (27.66) (13.45) (31.04) (22.42)
EV/EBIT
0.00 0.00 0.00 0.63 0.00 0.00 — 0.00 — 0.00
Other line items

Show all line items

Columns are period end dates